With our experimental setting we have shown for the first time that the DAMP HMGB1 is only released from HPV-positive HNSCC tumor cells after fractionated irradiation and that this can be significantly enhanced with taxane-based chemotherapy. The gene discussed is HMGB1; the disease is head and neck squamous cell carcinoma.